PARADIGM BIOCAPITAL ADVISORS LP Crinetics Pharmaceuticals, Inc. Transaction History

PARADIGM BIOCAPITAL ADVISORS LP portfolio value:

$10.19M
portfolio value

Crinetics Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 519.25K shares 10.19M $19.64 519.25K